Philipp Hofer
Impact in
-
- Genetic factors in colorectal cancer
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Clinical Laboratory Practices and Quality Control 5
- Telomeres, Telomerase, and Senescence 4
-
- Genetic factors in colorectal cancer 6
- Co-authors
- Helmuth Haslacher (6 shared papers)Thomas Perkmann (6 shared papers)Andrea Gsur (10 shared papers)Andreas Baierl (8 shared papers)Gernot Leeb (6 shared papers)M. Micksche (3 shared papers)Stephan Blüml (1 shared paper)Michael Markus Bonelli (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (5 papers)Oncotarget (3 papers)Nature Communications (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (2 papers)Carcinogenesis (1 paper)
- Partner nations
- AustriaUnited KingdomGermany
In The Last Decade
Philipp Hofer
31 papers receiving 1.5k citations
Philipp Hofer's Hit Papers
Peers
Comparison fields: 5 of 78
- Pathology and Forensic Medicine 366
- Infectious Diseases 318
- Genetics 451
- Oncology 250
- Cancer Research 69
Countries citing papers authored by Philipp Hofer
This map shows the geographic impact of Philipp Hofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Hofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Hofer more than expected).
Fields of papers citing papers by Philipp Hofer
This network shows the impact of papers produced by Philipp Hofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Hofer. The network helps show where Philipp Hofer may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Hofer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of common and rare genetic risk variants for colorectal cancer Hit paper breakdown → | 2018 | 401 |
| 2 | 2021 | 198 | |
| 3 | 2019 | 176 | |
| 4 | 2018 | 127 | |
| 5 | 2019 | 99 | |
| 6 | 2018 | 83 | |
| 7 | 2019 | 52 | |
| 8 | 2022 | 48 | |
| 9 | 2011 | 39 | |
| 10 | 2011 | 33 | |
| 11 | 2012 | 32 | |
| 12 | 2011 | 31 | |
| 13 | 2017 | 26 | |
| 14 | 2022 | 25 | |
| 15 | 2022 | 23 | |
| 16 | 2022 | 20 | |
| 17 | 2018 | 18 | |
| 18 | 2013 | 15 | |
| 19 | 2015 | 14 | |
| 20 | 2016 | 12 |
About Philipp Hofer
Philipp Hofer is a scholar working on Physiology, Pathology and Forensic Medicine, Infectious Diseases, Genetics and Public Health, Environmental and Occupational Health, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Clinical Laboratory Practices and Quality Control (5 papers), Genetic Associations and Epidemiology (5 papers), Telomeres, Telomerase, and Senescence (4 papers), Research Data Management Practices (3 papers), Ethics in Clinical Research (3 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (366 citations), Infectious Diseases (318 citations), Genetics (451 citations), Oncology (250 citations) and Cancer Research (69 citations). Philipp Hofer has collaborated with scholars based in Austria, United Kingdom and Germany. Frequent co-authors include Helmuth Haslacher, Thomas Perkmann, Andrea Gsur, Andreas Baierl, Gernot Leeb, M. Micksche, Stephan Blüml, Michael Markus Bonelli, Marlene C. Gerner and Marianne Graninger. Their work appears in journals such as Annals of the Rheumatic Diseases, Oncotarget, Nature Communications, Clinical Chemistry and Laboratory Medicine (CCLM) and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.